A phase II study of dose-intense ifosfamide plus epirubicin with hematopoietic growth factors for the treatment of patients with advanced soft tissue sarcomas; a novel sequential schedule - Concepedia

Concepedia

Publication | Closed Access

A phase II study of dose-intense ifosfamide plus epirubicin with hematopoietic growth factors for the treatment of patients with advanced soft tissue sarcomas; a novel sequential schedule

13

Citations

0

References

2001

Year

L. Serrone, Massimo Zeuli, Teresa Gamucci, Marco Nardi, F. Cognetti

Cancer Chemotherapy and Pharmacology

Surgical OncologyOncologyMetronomic TherapyPathologyPhase Ii StudyMetronomic ChemotherapyHematopoietic Growth FactorsCancer TreatmentMedicineRadiation OncologyNovel Sequential Schedule

No additional data available for this publication yet. Check back later!